To stop adverse evolution of atherosclerotic plaque burden: An appropriate objective for coronary artery disease therapy? - 02/12/22
Doi : 10.1016/j.acvd.2022.07.001
Gilles Barone-Rochette a, b, c, ⁎, 1 
a Université Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France
b Department of Cardiology, CHU Grenoble Alpes, 38000 Grenoble, France
c French Alliance Clinical Trial, French Clinical Research Infrastructure Network, 75018 Paris, France
*Corresponding author at: Clinique Universitaire de Cardiologie, Pôle Thorax et Vaisseaux, CHU de Grenoble, 38043 Grenoble CEDEX 09, France.Clinique Universitaire de Cardiologie, Pôle Thorax et Vaisseaux, CHU de GrenobleGrenoble CEDEX 0938043France
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Keywords : Coronary computed tomography angiography, Postprocessing software, Coronary atherosclerotic plaque burden
Abbreviations : CACS, CCTA, CT, IVUS, MACE, PAV
Esquema
| ☆ | Tweet: The screening and management of vulnerable coronary plaque remains a challenging problem, but serial coronary computed tomography angiography and the use of post-processing software to measure the evolution of coronary atherosclerotic plaque burden could rapidly resolve this problem. |
© 2022
Elsevier Masson SAS. Reservados todos los derechos.
Vol 115 - N° 11
P. 541-544 - novembre 2022 Regresar al número
Artículo precedente
- Editorial board
- Impact of procedural success on clinical outcome after MitraClip: Results from the MITRA-FR trial
- David Messika-Zeitoun, David Attias, Nicolas Piriou, Bernard Iung, Xavier Armoiry, Jean-Noël Trochu, Erwan Donal, Gilbert Habib, Bertrand Cormier, Patrice Guerin, Thierry Lefèvre, Delphine Maucort-Boulch, Florent Boutitie, Alec Vahanian, Benjamin Riche, Jean-Francois Obadia
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.